China has added dozens of new drugs to its health insurance reimbursement list, signalling support for innovative treatments while keeping…
Read More »Cancer
HutchMed aims to establish a bigger presence in the city when the first wet laboratories at the much larger Hong…
Read More »
Evive Biotech, a unit of Shenzhen-listed Yifan Pharmaceutical, aims to break the dominance of American drugs developer Amgen in the…
Read More »
Hutchison China MediTech (Chi-Med), whose stock has surged 70 per cent in London over the past six months, expects to…
Read More »
Three hospital systems across England have begun a live clinical trial of AI technology designed to detect and grade prostate…
Read More »
A collaborative study has uncovered microproteins exclusive to liver tumors, presenting a new avenue for cancer vaccine development. These microproteins…
Read More »
Dr. Jan Böttcher, group leader and TUM Junior Fellow at the Institute of Molecular Immunology at Klinikum rechts der Isar…
Read More »
In a major genetic study, over 5,000 variants linked to increased cancer risk were identified in the BAP1 gene, revealing…
Read More »
Developed by MIT researchers, Leuko’s device offers a noninvasive method for cancer patients to monitor their immune health at home.…
Read More »
A breakthrough treatment uses nutrient-based nanomedicine to reactivate dormant metabolic pathways in cancer cells, effectively stopping melanoma growth. This new…
Read More »